These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 4596666)
21. Vitamin E supplementation in people with cystic fibrosis: Summary of a Cochrane review. Barker B Explore (NY); 2021; 17(2):181. PubMed ID: 33388246 [No Abstract] [Full Text] [Related]
22. Chlorzoxazone (paraflex) in the treatment of severe spasticity. Losin S; McKean CM Dev Med Child Neurol; 1966 Dec; 8(6):768-9. PubMed ID: 5339683 [No Abstract] [Full Text] [Related]
23. [Clinical and biological study of the application of alpha-tocopheryl-quinone for 5 years of primary and secondary muscular diseases and for 1 case of scleroderma]. Turon R Sem Hop; 1968 Apr; 44(20):1375-9. PubMed ID: 4299465 [No Abstract] [Full Text] [Related]
24. Vitamin E supplementation in people with cystic fibrosis. Okebukola PO; Kansra S; Barrett J Cochrane Database Syst Rev; 2014 Dec; (12):CD009422. PubMed ID: 25489958 [TBL] [Abstract][Full Text] [Related]
25. The clinical effect of correction of vitamin E depletion in cystic fibrosis. Kelleher J; Miller MG; Littlewood JM; McDonald AM; Losowsky MS Int J Vitam Nutr Res; 1987; 57(3):253-9. PubMed ID: 3679696 [TBL] [Abstract][Full Text] [Related]
32. Letter: Effects of vitamin E: good and bad. N Engl J Med; 1973 Nov; 289(18):979-80. PubMed ID: 4200602 [No Abstract] [Full Text] [Related]
33. A trial of selenium and vitamin E in boys with muscular dystrophy. Gamstorp I; Gustavson KH; Hellström O; Nordgren B J Child Neurol; 1986 Jul; 1(3):211-4. PubMed ID: 3298399 [TBL] [Abstract][Full Text] [Related]
34. [Muscle metabolism and muscle disease; vitamin E, choline, inosit]. BECKMANN R Munch Med Wochenschr; 1952 Jun; 94(23):1176-81. PubMed ID: 12982787 [No Abstract] [Full Text] [Related]
35. Relative anemia and iron deficiency in cystic fibrosis. Ater JL; Herbst JJ; Landaw SA; O'Brien RT Pediatrics; 1983 May; 71(5):810-4. PubMed ID: 6835767 [TBL] [Abstract][Full Text] [Related]
36. Vitamin E status and its determinants in patients with cystic fibrosis. Sapiejka E; Krzyżanowska-Jankowska P; Wenska-Chyży E; Szczepanik M; Walkowiak D; Cofta S; Pogorzelski A; Skorupa W; Walkowiak J Adv Med Sci; 2018 Sep; 63(2):341-346. PubMed ID: 30081288 [TBL] [Abstract][Full Text] [Related]
37. [Therapy of myopathies]. Esslen E Bibl Psychiatr Neurol; 1969; 139():480-93. PubMed ID: 5406917 [No Abstract] [Full Text] [Related]
38. [Use of vitamin E in obstetrics and pediatrics (review of the literature)]. Kishko AM; Roshkovich IuV Vopr Okhr Materin Det; 1968 Sep; 13(9):67-70. PubMed ID: 4889354 [No Abstract] [Full Text] [Related]
39. Complementary therapies in cystic fibrosis: nutritional supplements and herbal products. Braga SF; Almgren MM J Pharm Pract; 2013 Feb; 26(1):14-7. PubMed ID: 23178411 [TBL] [Abstract][Full Text] [Related]
40. A study of the relationship between neurological function and serum vitamin E concentrations in patients with cystic fibrosis. Willison HJ; Muller DP; Matthews S; Jones S; Kriss A; Stead RJ; Hodson ME; Harding AE J Neurol Neurosurg Psychiatry; 1985 Nov; 48(11):1097-102. PubMed ID: 4078574 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]